NewsMarkets

Politics

FDA Delays Mifepristone Safety Review Until March

The agency will not impose new restrictions on the abortion drug before the review is published.

2 publishers · 2 articles · first seen 8 Oct 2026 · updated 2h ago

The story so far

2 publishers have covered this in 2 articles since 8 Oct 2026. The Hill published first, on 8 October at 02:33 UTC; CBS News Politics followed 7h 57m later. The most recent article, from CBS News Politics, appeared on 8 October at 10:30 UTC.

Outlets reporting it: The Hill (major outlet), CBS News Politics (major outlet).

No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.

Sources

Every article we clustered into this story. Headlines link to the publisher.

  1. FDA says its abortion pill safety review will continue into next year CBS News Politics ·
  2. FDA: mifepristone review won't be done until March The Hill ·

In this story

  • FDA
  • mifepristone
Embed this story

Paste this into any web page to show the live odds, with a link back here.